Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients
Alterations in the synthesis or enhanced inactivation of nitric oxide (NO) and an increase in endothelin-1 production lead to an imbalance that can induce arterial hypertension. Type II diabetes is characterized by impaired endothelium-dependent vasodilation and vascular disease. NO is produced thro...
Guardado en:
| Autor principal: | Ouvia, S.M |
|---|---|
| Otros Autores: | La Greca, R.D, Zanaro, N.L, Palmer, L., Sassetti, B. |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
2001
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
Ejemplares similares
-
Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients
por: Ouvia, S.M., et al. -
Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients
por: Sassetti, Beatriz
Publicado: (2001) -
Endothelin-1, nitric oxide and von Willebrand factor in hypertensive type 2 diabetic patients
por: Ouviña, S.M., et al. -
Endothelin-1, nitric oxide and von Willebrand factor in hypertensive type 2 diabetic patients
por: Ouviña, Susana María, et al.
Publicado: (2004) -
Arterial hypertension in patients with type 2 diabetes mellitus
por: Bendersky, Mario, et al.
Publicado: (2013)